Condition
Vein Disease
Total Trials
5
Recruiting
1
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Completed2
Active Not Recruiting1
Unknown1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05409976Not ApplicableActive Not Recruiting
The GORE® VIABAHN® FORTEGRA Venous Stent IVC Study
NCT05489588Not ApplicableRecruiting
The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study
NCT06231940Not ApplicableCompleted
Efficacy of Complex Decongestive Therapy (CDT) in Patients With Venous Insufficiency: a Experimental Study
NCT03202238Not ApplicableUnknown
TenTaTorch: Venepuncture Made Easy
NCT04154761Completed
Resection of the Inferior Vena Cava Due to Tumor Involvement
Showing all 5 trials